Sphere Medical of Cambridge, UK has received the European CE Mark for its Pelorus 1500 point-of-care system for measuring anesthetic propofol in blood samples.
The world’s first such system that avoids long turnaround time from the lab and allows actual measurements rather than predictions to be used, it was designed for clinical use in critical care environments where quick dosing decisions are particularly important.
From the announcement:
Sphere Medical expects the Pelorus 1500 to be used in conjunction with existing commercially available dosing pumps. Clinical studies have already shown that a single measurement carried out during general anaesthesia can significantly improve the clinicians’ understanding of propofol levels during an operation.
Sphere Medical is working with leading anaesthetists in the UK to investigate approaches to use propofol measurements during infusion to tailor the dose to the patient. This is expected to result in the next generation of infusion control systems which would be a significant opportunity to improve patient care and consequently is a large commercial opportunity.
Press release: Pelorus 1500 IVD Achieves CE Marking…